Hepatitis C in the Russian Federation: challenges and future directions

Sergey Mukomolov,† Galina Trifonova, Irina Levakova, Daria Bolsun, Eugenia KrivanogovaDepartment of Epidemiology, Saint-Petersburg Pasteur Institute, Saint Petersburg, the Russian Federation†Professor Sergey Mukomolov passed away on June 1, 2015Abstract: Hepatitis C virus (HCV)...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mukomolov S, Trifonova G, Levakova I, Bolsun D, Krivanogova E
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://doaj.org/article/9145fe01e5a14ef99b65dbfcd8f9cfd7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9145fe01e5a14ef99b65dbfcd8f9cfd7
record_format dspace
spelling oai:doaj.org-article:9145fe01e5a14ef99b65dbfcd8f9cfd72021-12-02T02:39:57ZHepatitis C in the Russian Federation: challenges and future directions1179-1535https://doaj.org/article/9145fe01e5a14ef99b65dbfcd8f9cfd72016-05-01T00:00:00Zhttps://www.dovepress.com/hepatitis-c-in-the-russian-federation-challenges-and-future-directions-peer-reviewed-article-HMERhttps://doaj.org/toc/1179-1535Sergey Mukomolov,† Galina Trifonova, Irina Levakova, Daria Bolsun, Eugenia KrivanogovaDepartment of Epidemiology, Saint-Petersburg Pasteur Institute, Saint Petersburg, the Russian Federation†Professor Sergey Mukomolov passed away on June 1, 2015Abstract: Hepatitis C virus (HCV) infection is one of the most prevalent health problems in the world. Official registration of HCV infections in the Russian Federation started in 1994. Two clinical forms of infection – acute and chronic hepatitis C – are registered separately. Moreover, the HCV national surveillance system also includes reports from laboratories on results from testing ~20 population risk groups for antibodies to HCV; approximately 15–16 million tests are performed annually. Modern epidemiological features of HCV infection in the Russian Federation are characterized by low incidence of the acute form of infection (acute HCV; one to two per 100,000) and a dramatic increase in chronic HCV (CHCV) cases. In 2013, the average nationwide rate of newly detected CHCV cases was 39.3/100,000. In the same year, the prevalence of CHCV demonstrating an accumulation of chronically infected patients in the country was much higher – 335.8/100,000. Four risk groups were identified as greatly affected by HCV, which were demonstrated by a high prevalence of antibodies to HCV: newborns from chronically infected women, persons from correctional facilities, patients with chronic liver diseases, and clients from clinics for sexually transmitted disease patients and drug users. It was found that several HCV genotypes circulated in different regions of the country; HCV1b had a prevalence of 55%–80% in almost every part of the country. However, in St Petersburg during the final decade of the last century and from 2001–2005, HCV3a subtype expanded circulation among young people due to increased intravenous drug addiction. Intravenous drug users were the major cause of a higher registration of double infection, with two different virus subtypes, and the appearance in Russia of new recombinant virus RF_2k/1b. It can be concluded that CHCV infection should be a focus of the health care system in Russia because serious epidemics of liver cirrhosis and hepatocellular carcinoma will be seen in the near future that will require urgent preventive and therapeutic measures.Keywords: hepatitis C, epidemiology, the Russian Federation, chronic hepatitis CMukomolov STrifonova GLevakova IBolsun DKrivanogova EDove Medical PressarticleHepatitis Cepidemiologythe Russian Federationchronic hepatitis CDiseases of the digestive system. GastroenterologyRC799-869ENHepatic Medicine: Evidence and Research, Vol 2016, Iss Issue 1, Pp 51-60 (2016)
institution DOAJ
collection DOAJ
language EN
topic Hepatitis C
epidemiology
the Russian Federation
chronic hepatitis C
Diseases of the digestive system. Gastroenterology
RC799-869
spellingShingle Hepatitis C
epidemiology
the Russian Federation
chronic hepatitis C
Diseases of the digestive system. Gastroenterology
RC799-869
Mukomolov S
Trifonova G
Levakova I
Bolsun D
Krivanogova E
Hepatitis C in the Russian Federation: challenges and future directions
description Sergey Mukomolov,† Galina Trifonova, Irina Levakova, Daria Bolsun, Eugenia KrivanogovaDepartment of Epidemiology, Saint-Petersburg Pasteur Institute, Saint Petersburg, the Russian Federation†Professor Sergey Mukomolov passed away on June 1, 2015Abstract: Hepatitis C virus (HCV) infection is one of the most prevalent health problems in the world. Official registration of HCV infections in the Russian Federation started in 1994. Two clinical forms of infection – acute and chronic hepatitis C – are registered separately. Moreover, the HCV national surveillance system also includes reports from laboratories on results from testing ~20 population risk groups for antibodies to HCV; approximately 15–16 million tests are performed annually. Modern epidemiological features of HCV infection in the Russian Federation are characterized by low incidence of the acute form of infection (acute HCV; one to two per 100,000) and a dramatic increase in chronic HCV (CHCV) cases. In 2013, the average nationwide rate of newly detected CHCV cases was 39.3/100,000. In the same year, the prevalence of CHCV demonstrating an accumulation of chronically infected patients in the country was much higher – 335.8/100,000. Four risk groups were identified as greatly affected by HCV, which were demonstrated by a high prevalence of antibodies to HCV: newborns from chronically infected women, persons from correctional facilities, patients with chronic liver diseases, and clients from clinics for sexually transmitted disease patients and drug users. It was found that several HCV genotypes circulated in different regions of the country; HCV1b had a prevalence of 55%–80% in almost every part of the country. However, in St Petersburg during the final decade of the last century and from 2001–2005, HCV3a subtype expanded circulation among young people due to increased intravenous drug addiction. Intravenous drug users were the major cause of a higher registration of double infection, with two different virus subtypes, and the appearance in Russia of new recombinant virus RF_2k/1b. It can be concluded that CHCV infection should be a focus of the health care system in Russia because serious epidemics of liver cirrhosis and hepatocellular carcinoma will be seen in the near future that will require urgent preventive and therapeutic measures.Keywords: hepatitis C, epidemiology, the Russian Federation, chronic hepatitis C
format article
author Mukomolov S
Trifonova G
Levakova I
Bolsun D
Krivanogova E
author_facet Mukomolov S
Trifonova G
Levakova I
Bolsun D
Krivanogova E
author_sort Mukomolov S
title Hepatitis C in the Russian Federation: challenges and future directions
title_short Hepatitis C in the Russian Federation: challenges and future directions
title_full Hepatitis C in the Russian Federation: challenges and future directions
title_fullStr Hepatitis C in the Russian Federation: challenges and future directions
title_full_unstemmed Hepatitis C in the Russian Federation: challenges and future directions
title_sort hepatitis c in the russian federation: challenges and future directions
publisher Dove Medical Press
publishDate 2016
url https://doaj.org/article/9145fe01e5a14ef99b65dbfcd8f9cfd7
work_keys_str_mv AT mukomolovs hepatitiscintherussianfederationchallengesandfuturedirections
AT trifonovag hepatitiscintherussianfederationchallengesandfuturedirections
AT levakovai hepatitiscintherussianfederationchallengesandfuturedirections
AT bolsund hepatitiscintherussianfederationchallengesandfuturedirections
AT krivanogovae hepatitiscintherussianfederationchallengesandfuturedirections
_version_ 1718402303184076800